Cargando…
The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer
Molecular classifications of breast cancer (BRC), such as human epidermal growth factor receptor 2 (HER2), luminal A and luminal B, have been developed to reduce unnecessary treatment by dividing patients with BRC into low- and high-risk progression groups. However, these methods do not cover all of...
Autores principales: | Kim, Seon-Kyu, Kim, Kwangho, Ryu, Jea-Woon, Ryu, Tae-Young, Lim, Jung Hwa, Oh, Jung-Hwa, Min, Jeong-Ki, Jung, Cho-Rok, Hamamoto, Ryuji, Son, Mi-Young, Kim, Dae-Soo, Cho, Hyun-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254934/ https://www.ncbi.nlm.nih.gov/pubmed/30365075 http://dx.doi.org/10.3892/ijo.2018.4608 |
Ejemplares similares
-
EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression
por: Lee, Jinkwon, et al.
Publicado: (2021) -
Novel prognostic marker PRMT1 regulates cell growth via downregulation of CDKN1A in HCC
por: Ryu, Jea-Woon, et al.
Publicado: (2017) -
Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer
por: Ryu, Tae Young, et al.
Publicado: (2022) -
Epigenetic Silencing of CHOP Expression by the Histone Methyltransferase EHMT1 Regulates Apoptosis in Colorectal Cancer Cells
por: Kim, Kwangho, et al.
Publicado: (2022) -
SETDB1 regulates SMAD7 expression for breast cancer metastasis
por: Ryu, Tae Young, et al.
Publicado: (2019)